From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
about
Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingNew insights in hepatocellular carcinoma: from bench to bedsideDietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats.Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancerRecombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 productionOverexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinomaSorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells.Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinomaCould HBx protein expression affect signal pathway inhibition by gefitinib or selumetinib, a MEK inhibitor, in hepatocellular carcinoma cell lines?Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitisExpression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia.The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cellsKnockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.Array-based profiling of the differential methylation status of CpG islands in hepatocellular carcinoma cell lines.BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular Carcinoma.Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation.Therapeutic approaches to target cancer stem cells.Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activationRNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade.BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing.Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms.Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.mTOR inhibitors for hepatocellular cancer: a forward-moving target.FACS-assisted microarray profiling implicates novel genes and pathways in zebrafish gastrointestinal tract development.Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma.Targeted therapy of hepatocellular cancer.Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.Current status of radiofrequency ablation of hepatocellular carcinoma.Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenibCellular and molecular mechanisms of hepatocellular carcinoma: an update.Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation.
P2860
Q26783895-AEFCC5F0-5577-4C56-ABB4-69E8C2693DA9Q27026454-F1D241E0-0E02-4944-993C-AABB0037B000Q33691490-74F14286-8CDE-464D-A677-F52CC8871695Q33767713-5D06FF8B-F1C3-4991-BE9C-2A431B58E1E5Q33798661-40195C09-0428-411D-B55F-1B07F8B1C4FBQ33965228-35A670AF-EFEF-472A-9A1C-2CADF82D512BQ33986185-626CB075-D905-4FB7-9BE6-E48108AFBD23Q34037880-9889FA59-954E-4B59-A6C1-68F0238FC2C4Q34104350-71655431-D99A-47C4-9304-11F8BD45EB0AQ34218232-0B67DF8A-9938-4D8B-B09C-DEC47A1906BFQ34359262-71A227DC-FAD8-42ED-ADAD-70DFFB5FDAF7Q34539948-3AC41EC0-DADD-4117-A6E7-0393BDD01961Q34632966-26C1261D-BFA9-4823-8418-1B9F9258DE62Q35166192-726AC392-FB4F-44ED-9F6D-435AAFC407A5Q35778023-E9BBE894-8063-41E0-A331-CD7544FE7F64Q35832233-D462322A-572D-4B7F-B4E0-7AB63AB125FEQ35934472-A347BB7C-F4BD-453A-941A-75EA1DC86E94Q36216577-07BED744-18F9-4E8E-99D3-6F26A73D4599Q36299655-1880D328-F170-43F0-BCC4-676F159D1668Q36836945-FD268AA7-21CD-4438-852B-AE6F7B30A68FQ36857866-B22F786D-8C81-4725-9F09-1032560254A1Q36922674-181C39A7-25BA-4697-8FDA-E1CD8159AABAQ37137412-C5463B4C-EED7-4D8B-B995-475D22F9F45BQ37172903-D476C3F5-C38D-48BE-B3CF-EB6DE2273FD6Q37247071-8B73F327-135A-44EA-9FE1-A74AB8A26A3CQ37268123-AD642AFE-4640-46B5-9EDA-9D8D19F5F85AQ37268127-B3D4E039-E3B7-4A3F-8F97-8EBA36C35B6EQ37317180-5CE74941-CC24-4B01-9552-BCDDAB90D0D1Q37356433-8A8C5CA6-720C-45F3-BE3F-FC77C8EEEDB9Q37385392-C9172274-5AA3-4360-AA3F-362F20DE2DFFQ37445720-69FFF4B7-D7F0-4E5B-9BEC-6E27A1553AEFQ37564060-48E0285F-8840-4834-B0E2-865ED8A90036Q37674624-24085503-9D74-4CD8-B5D1-FCF5E7C4C9AFQ37745129-FDB77B12-CC24-4D55-98D9-BEA22A4FDBE5Q37779804-396A88B2-20E3-489C-BF5F-2C3115B62536Q37821277-F99C14C2-0ACA-4924-9CEE-E93C5642E939Q37821302-5CF70D7C-BAAA-4CD7-BDC3-8371E47DD4A9Q38046107-397FF65D-3125-4D02-9576-DCAA42760FE9Q38174863-1395630C-DDE9-41FF-8EB9-675DDF5F58A7Q38464474-D2215C69-4318-4762-9B30-7CC19DAF926F
P2860
From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
From molecular biology to targ ...... carcinoma: the future is now.
@en
From molecular biology to targ ...... carcinoma: the future is now.
@nl
type
label
From molecular biology to targ ...... carcinoma: the future is now.
@en
From molecular biology to targ ...... carcinoma: the future is now.
@nl
prefLabel
From molecular biology to targ ...... carcinoma: the future is now.
@en
From molecular biology to targ ...... carcinoma: the future is now.
@nl
P2860
P356
P1433
P1476
From molecular biology to targ ...... carcinoma: the future is now.
@en
P2093
Roberta W C Pang
Ronnie T P Poon
P2860
P356
10.1159/000111705
P478
72 Suppl 1
P577
2007-12-13T00:00:00Z